Evidence map›Paper›PMID 42538427›Full record

ArticleNature medicine2026

End-to-end multimodal pathology foundation model with clinical dialogue.

Eugene Vorontsov, George Shaikovski, Adam Casson, Julian Viret, Eric Zimmermann, Neil Tenenholtz, Yi Kan Wang, Jan H Bernhard, Ran A Godrich, Juan A Retamero and 9 more

Abstract read
In one paragraph

Article in Nature medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Eugene Vorontsov *Paige, New York, NY, USA. eugene.vorontsov@paige.ai.ORCID http://orcid.org/0000-0002-4530-533X
George Shaikovski *Paige, New York, NY, USA.ORCID http://orcid.org/0009-0009-8475-9594
Adam Casson *Paige, New York, NY, USA.
Julian Viret *Paige, New York, NY, USA.
Eric Zimmermann *Microsoft Research, Cambridge, MA, USA.ORCID http://orcid.org/0009-0009-6805-1561
Neil TenenholtzMicrosoft Research, Cambridge, MA, USA.ORCID http://orcid.org/0000-0003-1250-3716
Yi Kan WangPaige, New York, NY, USA.
Jan H BernhardPaige, New York, NY, USA.ORCID http://orcid.org/0009-0003-0381-355X
Ran A GodrichPaige, New York, NY, USA.
Juan A RetameroPaige, New York, NY, USA.
Jinru ShiaMemorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0002-4351-2511
Mithat GonenMemorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0001-8683-8477
Martin R WeiserMemorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0002-9577-7984
David S KlimstraYale University, New Haven, CT, USA.
Razik YousfiPaige, New York, NY, USA.
Nicolò FusiMicrosoft Research, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-4102-0169
Thomas J FuchsPaige, New York, NY, USA.
Kristen SeversonMicrosoft Research, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-0412-4217
Siqi LiuPaige, New York, NY, USA.ORCID http://orcid.org/0000-0002-4169-7567

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Recent rapid progress in the field of computational pathology has been enabled by foundation models. These models are beginning to move beyond encoding image patches toward whole-slide understanding, but their clinical utility remains limited. Here we present PRISM2, a multimodal slide-level foundation model trained on 2.3 million whole-slide images and 14 million question-answer pairs derived from 700,000 pathology reports. Through clinical dialogue supervision, PRISM2 aligns histomorphology with diagnostic reasoning, yielding representations that support both prompt-based inference and transferable embeddings for downstream tasks. With prompt-based inference, PRISM2 achieves or exceeds (P < 0.05) the balanced accuracy of clinical-grade products calibrated for cancer detection in the prostate, breast and breast lymph node. Additionally, across comprehensive diagnostic, biomarker and survival benchmarks, PRISM2 embeddings never statistically underperform previous foundation models via linear probing (P < 0.05). Furthermore, task-specific fine-tuning on survival prediction outperforms training from scratch on the same large survival dataset. PRISM2 demonstrates how language-supervised pretraining provides a scalable, clinically grounded signal for generalizable pathology representations, bridging human diagnostic reasoning and foundation model performance.

Indexed as

Image Interpretation, Computer-AssistedBreast NeoplasmsFemaleHumansMaleProstatic Neoplasms

Identifiers

PMID42538427
PMCPMC13577907

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.